about
Unsolved Puzzles Surrounding HCV Immunity: Heterologous Immunity Adds Another Dimension.Impact of an electronic health record alert in primary care on increasing hepatitis c screening and curative treatment for baby boomers.Assessing risk of fibrosis progression and liver-related clinical outcomes among patients with both early stage and advanced chronic hepatitis C.Risk Assessment of Hepatocellular Carcinoma in Patients with Hepatitis C in China and the USA.Race affects SVR12 in a large and ethnically diverse hepatitis C-infected patient population following treatment with direct-acting antivirals: Analysis of a single-center Department of Veterans Affairs cohort.A Guide to the Economics of Hepatitis C Virus Cure in 2017The need for a European hepatitis C programme monitoring resistance to direct-acting antiviral agents in real life to eliminate hepatitis CEfficacy of an 8-week course of sofosbuvir and ledipasvir for the treatment of HCV infection in selected HIV-infected patients
P2860
Q40106073-F2ACF9A1-7860-4AA6-82D3-C61464CAFE78Q40120487-15972F14-B81E-49E2-AF89-8E7CCDF591DCQ45944112-DEEFC612-23F9-4653-A6B6-27605EA282C6Q47631237-73F64B6A-D128-42E5-8048-96BD0355BC73Q55259186-880BD895-CB61-4F57-A1BC-388D7476C92DQ56654943-A0F0FB1D-8291-413A-BAD4-6D80B39B9A9FQ56830533-3A6D67C4-3560-416C-BEC6-D9F275994999Q57827106-4F8FACFE-03F6-462C-9422-93061A28DC57
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Hepatitis C Treatment and Barriers to Eradication.
@en
type
label
Hepatitis C Treatment and Barriers to Eradication.
@en
prefLabel
Hepatitis C Treatment and Barriers to Eradication.
@en
P2860
P356
P1476
Hepatitis C Treatment and Barriers to Eradication.
@en
P2093
Anna S F Lok
Monica A Konerman
P2860
P356
10.1038/CTG.2016.50
P577
2016-09-22T00:00:00Z